Study of GATA2 gene changes over time
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how GATA2 gene changes affect your blood cells over time. It is for people of any age who have a GATA2 mutation they were born with, and it does not test a new drug—just collects information and samples during regular checkups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a GATA2 mutation that you were born with (not one acquired later in life).
- You are being cared for at Institut Claudius Regaud or another participating center.
- You (or your parent/guardian) can sign a consent form agreeing to join the study.
- If you are in France, you have health insurance through the French system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This natural history study looks at how GATA2 deficiency (a genetic condition) affects health over time. It may help doctors better understand complications and plan future care, and it includes genetic testing and stored samples.
This trial tests whether an allogeneic bone marrow (stem cell) transplant can improve outcomes for people with GATA2 gene changes or “MonoMAC” syndrome. It aims to rebuild a healthier immune system in patients who have serious infections and immune cell deficiencies.
This study tracks the health of people with a confirmed ACTA2 gene change over time to better understand the disease. It may help researchers learn how to improve care for this condition.
This study collects DNA and medical information to better understand germ cell and testicular tumors and possible inherited genetic causes. It may help researchers sort out how genetic changes relate to these cancers, even if you’re not receiving a new drug.
This study follows people with a TANGO2 gene change and collects medical information and samples over time. It aims to better describe the condition and build a biorepository (a secure collection of samples) to support future research.
This study looks at “molecular” (DNA-related) features of germ cell tumors in children and teens. It also follows patients over time, which can help researchers understand tumor patterns and improve future care.
Hear when a new GATA2 Gene Mutation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.